The Latest Breaking News from FDA

Here's a roundup of top developments in the biotech space over the last 24 hours:

The U.S. Preventive Services Task Force issued a recommendation statement in June 2022 on the use of over-the-counter vitamin supplements. Based on its independent panel of experts’ review of existing scientific evidence, the task force recommended against using beta carotene or vitamin E supplements for the prevention of cancer and…

CNBC United Airlines, Pilots’ Union To Improve Agreement By Renegotiating

In the nearly three weeks since the U.S. Supreme Court overturned Roe v. Wade, abortion has become illegal in at least 10 states, with more states to follow in the weeks ahead.

Birth control pills are available in the U.S. only with a prescription. Now a drugmaker is asking the FDA to approve a progestin-only contraceptive that would be available without one at pharmacies.

The FDA has vowed to take more action in the coming weeks.

The pharmaceutical firm says Health Canada will screen its Accrufer lead product, with an outcome expected next year

Novavax Inc.’s COVID-19 vaccine was cleared by U.S. regulators, giving Americans another tool against the virus as cases start to rise again.

Approval of shot widens options against the virus as CDC will meet next week to decide whether to sign off on vaccine

The U.S. is getting another COVID-19 vaccine choice

The protein-based vaccine still needs to be approved by the CDC before it can start to be administered